Mannkind (MNKD) Other Gross PP&E Adjustments (2011 - 2026)
Mannkind (MNKD) reported Other Gross PP&E Adjustments of $186.0 million for Q1 2026, up 3.74% year-over-year from $179.3 million in Q1 2025, and up 1.37% on a QoQ basis from $183.5 million in Q4 2025.
Mannkind (MNKD) has 16 years of Other Gross PP&E Adjustments data on file, last reported at $186.0 million in Q1 2026.
- Quarterly Other Gross PP&E Adjustments rose 3.74% year-over-year to $186.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $186.0 million (up 3.74% YoY) and the FY2025 annual result came in at $183.5 million, up 38.94% from the prior year.
- Other Gross PP&E Adjustments rose to $186.0 million in Q1 2026 per MNKD's latest filing, from $183.5 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $186.0 million in Q1 2026 and bottomed at $129.3 million in Q4 2022.
- The 5-year median for Other Gross PP&E Adjustments is $163.6 million (2023), against an average of $158.3 million.
- The widest annual swing landed in 2024, when Other Gross PP&E Adjustments decreased 25.6%; it then soared 38.94% in 2025.
- Tracing MNKD's Other Gross PP&E Adjustments over 5 years: stood at $129.3 million in 2022, then jumped by 37.3% to $177.5 million in 2023, then declined by 25.6% to $132.1 million in 2024, then jumped by 38.94% to $183.5 million in 2025, then rose by 1.37% to $186.0 million in 2026.
- Per Business Quant, the three latest MNKD Other Gross PP&E Adjustments figures stand at $186.0 million (Q1 2026), $183.5 million (Q4 2025), and $182.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 186.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 186.01 Mn |
| Mar 31, 2026 | 186.01 Mn |
| Dec 31, 2025 | 183.50 Mn |
| Dec 31, 2025 | 183.50 Mn |
| Sep 30, 2025 | 182.39 Mn |
| Sep 30, 2025 | 182.39 Mn |
| Jun 30, 2025 | 179.90 Mn |
| Jun 30, 2025 | 179.90 Mn |
| Mar 31, 2025 | 179.32 Mn |
| Mar 31, 2025 | 179.32 Mn |
| Dec 31, 2024 | 132.07 Mn |
| Dec 31, 2024 | 132.07 Mn |
| Sep 30, 2024 | 134.27 Mn |
| Sep 30, 2024 | 134.27 Mn |
| Jun 30, 2024 | 141.55 Mn |
| Jun 30, 2024 | 141.55 Mn |
| Mar 31, 2024 | 181.45 Mn |
| Mar 31, 2024 | 181.45 Mn |
| Dec 31, 2023 | 177.51 Mn |
| Dec 31, 2023 | 177.51 Mn |
| Sep 30, 2023 | 175.99 Mn |
| Sep 30, 2023 | 175.99 Mn |
| Jun 30, 2023 | 163.58 Mn |
| Jun 30, 2023 | 163.58 Mn |
| Mar 31, 2023 | 147.99 Mn |
| Mar 31, 2023 | 147.99 Mn |
| Dec 31, 2022 | 129.29 Mn |
| Dec 31, 2022 | 129.29 Mn |
| Sep 30, 2022 | 132.62 Mn |
| Sep 30, 2022 | 132.62 Mn |
| Jun 30, 2022 | 132.98 Mn |
| Jun 30, 2022 | 132.98 Mn |
| Mar 31, 2022 | 130.66 Mn |
| Mar 31, 2022 | 130.66 Mn |
| Dec 31, 2021 | 121.61 Mn |
| Dec 31, 2021 | 121.61 Mn |
| Sep 30, 2021 | 126.48 Mn |
| Sep 30, 2021 | 126.48 Mn |
| Jun 30, 2021 | 124.94 Mn |
| Jun 30, 2021 | 124.94 Mn |
| Mar 31, 2021 | 122.15 Mn |
| Mar 31, 2021 | 122.15 Mn |
| Dec 31, 2020 | 118.92 Mn |
| Dec 31, 2020 | 118.92 Mn |
| Sep 30, 2020 | 122.03 Mn |
| Sep 30, 2020 | 122.03 Mn |
| Jun 30, 2020 | 121.96 Mn |
| Jun 30, 2020 | 121.96 Mn |
| Mar 31, 2020 | 121.97 Mn |
| Mar 31, 2020 | 121.97 Mn |
| Dec 31, 2019 | 119.01 Mn |
| Dec 31, 2019 | 119.01 Mn |
| Sep 30, 2019 | 128.15 Mn |
| Sep 30, 2019 | 128.15 Mn |
| Jun 30, 2019 | 127.67 Mn |
| Jun 30, 2019 | 127.67 Mn |
| Mar 31, 2019 | 125.74 Mn |
| Mar 31, 2019 | 125.74 Mn |
| Dec 31, 2018 | 123.55 Mn |
| Dec 31, 2018 | 123.55 Mn |
| Sep 30, 2018 | 126.53 Mn |
| Sep 30, 2018 | 126.53 Mn |
| Jun 30, 2018 | 126.54 Mn |
| Jun 30, 2018 | 126.54 Mn |
| Mar 31, 2018 | 126.55 Mn |
| Mar 31, 2018 | 126.55 Mn |
| Dec 31, 2017 | 120.87 Mn |
| Dec 31, 2017 | 120.87 Mn |
| Sep 30, 2017 | 127.01 Mn |
| Sep 30, 2017 | 127.01 Mn |
| Jun 30, 2017 | 127.42 Mn |
| Jun 30, 2017 | 127.42 Mn |
| Mar 31, 2017 | 127.00 Mn |
| Mar 31, 2017 | 127.00 Mn |
| Dec 31, 2016 | 111.17 Mn |
| Dec 31, 2016 | 111.17 Mn |
| Sep 30, 2016 | 166.14 Mn |
| Sep 30, 2016 | 166.14 Mn |
| Jun 30, 2016 | 167.44 Mn |
| Jun 30, 2016 | 167.44 Mn |
| Mar 31, 2016 | 167.46 Mn |
| Mar 31, 2016 | 167.46 Mn |
| Dec 31, 2015 | 151.32 Mn |
| Dec 31, 2015 | 151.32 Mn |
| Sep 30, 2015 | 316.76 Mn |
| Sep 30, 2015 | 316.76 Mn |
| Jun 30, 2015 | 317.02 Mn |
| Jun 30, 2015 | 317.02 Mn |
| Mar 31, 2015 | 314.00 Mn |
| Mar 31, 2015 | 314.00 Mn |
| Dec 31, 2014 | 310.35 Mn |
| Dec 31, 2014 | 310.35 Mn |
| Sep 30, 2014 | 309.07 Mn |
| Sep 30, 2014 | 309.07 Mn |
| Jun 30, 2014 | 299.33 Mn |
| Jun 30, 2014 | 299.33 Mn |
| Mar 31, 2014 | 289.92 Mn |
| Mar 31, 2014 | 289.92 Mn |
| Dec 31, 2013 | 287.62 Mn |
| Dec 31, 2013 | 287.62 Mn |
| Sep 30, 2013 | 287.74 Mn |
| Sep 30, 2013 | 287.74 Mn |
| Jun 30, 2013 | 286.61 Mn |
| Jun 30, 2013 | 286.61 Mn |
| Mar 31, 2013 | 286.53 Mn |
| Mar 31, 2013 | 286.53 Mn |
| Dec 31, 2012 | 285.21 Mn |
| Dec 31, 2012 | 285.21 Mn |
| Sep 30, 2012 | 286.08 Mn |
| Sep 30, 2012 | 286.08 Mn |
| Jun 30, 2012 | 285.40 Mn |
| Jun 30, 2012 | 285.40 Mn |
| Dec 31, 2011 | 284.79 Mn |
| Dec 31, 2011 | 284.79 Mn |